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I. INTRODUCTION
The distinction between true myopathic disease and functional
disorders of skeletal muscle secondary to neuronal degeneration was
fully developed by the work of Erb (1891). The disease, known today as
muscular dystrophy, was first reported by Meryon (1864). He remarked
on what appeared to be a disease restricted to skeletal muscle and
suggested the cause to be a nutritional deficiency. Eulenberg (1866 ),
Duchenne {1868) and Sachs {1888) subsequently verified the existence of
muscular dystrophy as a clinical entity. Muscular dystrophy is distinguished as a condition of depressed functional capacity secondary to a
primary granular and fatty degeneration of skeletal muscle fibers, whose
etiology is unknown. The disease is conceded by all to be hereditarily
transmitted. Bell (1943), Boyes, Fraser, Lawler and MacKensie (1949)
and Tyler and Stephens (1950) have all reported the disease to be inherited as a sex-linked Mendalian dominant characteristic.
As muscular dystrophy is transmitted genetically, it is obvious that the
disease cannot be artificially transmitted to an experimental animal. Because of this fact, the data that has accumulated has been of human clinical
evaluations, muscle biopsy studies and post-mortem examinations. Therefore, with the discovery of a primary, hereditarily-induced myopathy in an
inbred strain of mice (Ivlichelson, Russell and Harman, 1955) new interest
in basic research of muscular dystrophy has been generated. The similarities of this mouse dystrophy (called "dystrophia muscularis" by Michelson,
Russell and Harman, 1955) and human muscular dystrophy are many
I

(see "Review of the Literature"). Because of these similarities, this
animal has proved itself to be a valuable research tool in the study of
muscular dystrophy.
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II.

REVIEW OF THE LITERATURE

Mice exhibiting a form of muscular dystrophy were noted in an apparent
mutation of breeding stock of inbred strain 129 mice at the Jackson
Memorial Laboratory, Bar, Harbor, Maine. According to Michelson,
Russell and Harman (1955), the disease is characterized by muscular
weakness, gross atrophy of the muscles and progressive ataxia. They
described paresis, kyphosis, convulsive nodding of the head, spasmodic
flexion and flaccid extension of the hind limbs. There was eventual complete
loss of locomotor function and premature death. The affected animals do
not live a sufficient length of time to permit breeding. Stevens, Russell
and Southard (1957) transplanted the ovaries of dystrophic mice into the
ovarian capsules of normal female mice.

The normal mouse was then

bred and bore young. Part of this litter exhibited dystrophy. By this means,
the latter authors were not only able to develop a stock of mice suffering from
muscular dystrophy but were able to show that the inheritance of the disease
followed the pattern of a single, autosomal recessive gene. Wolfe and
Southard (1962) refined these methods, using artificial insemination to produce
litters of all dystrophic offspring. Further work lead Russell and others
(1962) to a new F1 strain, breeding the 129 Re-dy (dystrophic) mice and
C57BC/6J-dy mice. These new animals have been found to possess similar
anatomical, physiological and biochemical properties as noted in the 129
Re-dy strain.
After the initial report by Michelson, Russell and Harman (1955), an increasing number of laboratories turned their attention to this strain of mice
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as a valuable research tool for the study of muscular dystrophy. Sandow
and Brust (1958) found that the dystrophic muscle of these mice was weaker
(directly or in tension developed per gram of muscle), exhibiting less
shortening when tension was applied. The contraction times were normal,
but the relaxation times were increased threefold. At rest, both dystrophic
and normal muscle possessed non-linear elasticity, but the diseased muscle
was "stiffer". They also noted that the active state duration (that time in
which the muscle is doing work) was shorter. Sandow and Brust (1962) also
noted slower relaxation times and concluded that dystrophic muscle develops
fatigue more slowly, but Solton (1962), in observing the swimming ability
of dystrophic mice noted that these affected mice fatigued more rapidly.
The electromygraphic studies of Mcintyre, Bennett and Brodkey (1959)
indicated that dystrophic muscle possessed a hyperirritability to mechanical
stimulation. The muscles exhibited spontaneous high-frequency volleys and
fibrillation. Both the high frequency volleys and fibrillary potentials continued
undisturbed after nerve block. Similar observations in humans by these same
authors led them to conclude that the condition of these mice corresponded
closely to clinical electromygraphic patterns of human dystrophia myotonica.
Kleeman, Partridge and Glaser (1961) also noted these variations and further
reported that the resting potentials of the dystrophic muscles were lower than
the normals. The observation that alteration of the intra and

extra~ellular

ion concentrations had no different effect in response to electrical activity of
dystrophic muscle as compared to normal control muscle was made by
McLennan (1961). The electrical activity of myocardial muscles was explored
by Kleinfeld, Magin, Murphy and Stein (1961) who found no change in intracellular potential or maximum tension output in dystrophic mice as compared
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to their littennate controls.
West and Murphy (1960) studied the histological picture of dystrophic
muscle of these mice and reported that the extreme variation of fiber size
was the most conspicuous change. They noted that in cross-sections of
the tissue the fibers round up and many become hypertrophied. There was
a relative and absolute increase in connective tissue. This was due to the
thickening of the endomysium and some fatty replacement. There was an
increase in the number of nuclei and the nuclei were larger, more vesicular
and exhibited internuclear rowing (the nuclei appeared as a string of beads).
The sections showed coagulation necrosis, with some subsequent regeneration
from isolated muscle nuclei and plasmodial budding. In the opinion of West
and Murphy (1960), the existing morphological differences between mouse
dystrophy and human dystrophy "are ones of degree rather than kind, and
do not rule out the possibility of important similarities in mechanism and
etiology." The "rowing" of the nuclei was also reported by Ross, Pappas
and Harman (1960), who further noted that the myofibrils broke down by
fragmentation and dissolution only in that region of the muscle cell where
internuclear rowing was occurring. It was also observed that the mitochondria were less dense and were significantly larger with an irregular
shape, probably due to swelling; the endoplasmic reticulum appeared
distended or swollen in the dystrophic cells, but the sarcolemma and nuclei
appeared to be normal. Kitigakara (1961) stated that the nuclei appeared
consistent with those of non-proliferating tissue. His studies, utilizing
p32 for radioautography of RNA and DNA, revealed only RNA synthesis.
Jasmin and Bajusz (1962), noted myocardial lesions to be present late in the
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disease, resembling those found in human muscular dystrophy, thus
finding a similarity not noted before.
Brat, Shull, Alfin-Slater and Ershoff (1960) studied the development
of the long bones. They found that the dystrophic animal showed a premature closure of the epiphyseal plate. They noted osteoporosis with
complete loss of trabeculae in the epiphysis and diaphysis at 12, 16 or
20 weeks of age. It was their hypothesis that these changes were not due
to disuse, but possibly due to changes in blood flow. It may be of
significance that they could not find any evidence of change in bone in
animals of 6 weeks of age. Leonard (1957) had earlier reported that the
width of the tibial epiphyseal cartilages in the dystrophic mice was less
than normal.
The effect of denervation on the dystrophic muscle has been subjected
to investigation. Banker and Denny-Brown (1959) found that, (1) "after
denervation, progressive smallness of fibers in genetically determined
dystrophy (in mice) was the most evident histological characteristic",
(2) the turnover of c14-creatine was increased in the denervated muscle,
(3) the greatest decrease in the creatine index (gm creatine/gm noncollagon nitrogen) was found in denervated dystrophic muscle and, (4)
after denervation, simple atrophy of dystrophic fibers was increased.
Baker, Wilson, Oldendorf and Blahd (1960) suggested that the muscle of
the dystrophic animals, like denervated normal muscle was supersensitive to acetylcholine.
The physiology and biochemistry of the dystrophic muscle has been
studied by a number of investigators. Coleman and Ashworth (1959) found
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that in mice two months of age, there is an increase of 603 in the content
of desoxyribonucleic acid (DNA) and 403 in that of ribonucleic acid (RNA)
per gram of muscle wet weight. They reported the uptake of glycine1-cl4 was 25-403 faster in dystrophic skeletal muscle. Because the
dystrophic mice did not gain weight they concluded that the synthesis of
muscle tissue was increased to compensate for the degeneration. Radioautographic studies by Walker (1962) have shown that dystrophic muscle
is able to regenerate. Simon, Lessell, Gross and Milhorat (1958) worked
with dl-leucine-1-cl4 and reported a higher incorporation rate into
muscle over a 2-24 hour period, while the rate of disappearance of the
isotopic carbon over a 20-30 day period from the dystrophic muscle was
more rapid than normal. From this data, they postulated, "the loss of
muscle protein in this mouse myppathy is not the result of a defect in
protein synthesis, but of a more rapid turnover in which the greater rate
of synthesis is exceeded by the increased rate of catabolism." This view
is also held by Simon, Gross and Lessell (1962).

Kruh, Dreyfus, Schapira

and Gey (1960) studied the turnover of glycine-2-cl4 in myosin and waterextractable proteins in normal mice (strain RAP), dystrophic mice and
normal littermate mice (strain 129). They noted an increased uptake of
the radioactive substance in both myosin and the water-extractable proteins
in the dystrophic mice muscles. An increased rate of turnover was also
observed in these same animals. According to these authors, "these results
can be interpreted as representing a shorter life span of the muscle cell,
or of a part of the cell or, more likely, as an acceleration of the turnover
of the muscle proteins." Walker (1962) felt that this rapid turnover
7

reflected an accelerated taging', thus the dystrophic muscle becomes
'oldt before the rest of the tissues.

Weinstock, Epstein and Milhorst

(1956) showed that the total niµ-ogen contents of dystrophic muscle were
reduced and the collagen nitrogen was increased when compared to
normal muscle on a wet weight basis, but in terms of dry weight the
percentage of the nitrogen fractions was unchanged. Baker, Tubis and
Blahd (1958) found that the metabolic rate, measured by collecting the
expired air and measuring the carbon diexide production, was normal in
dystrophic mice. However, Rosenkrantz and Laforte (1960) measured the
oxygen consumption of tissue slices of dystrophic muscle using the
Warburg apparatus. They reported an increase in oxygen consumption
in a range of 40-122% in their various samples. It was reported by
Borgman (1962) that there were no differences noted in oxygen uptake
of tissue slices between various dystrophic animal tissues and normal
littermate controls. The apparent discrepancies between these studies
may be explained on the basis of different techniques. Baker, Tubis and
Blahd (1958) also reported that the oxidation of acetate-1-cl 4 , measured
as c1402 in the expired air, was at the same rate in dystrophic mice as
in normal mice. Baker, Blahd and Hart (1958) showed that the muscles of
dystrophic mice contained less potassium but more sodium than do the
normal controls. The values of 12-23% less potassium and 68-107% more
sodium, based on the fat-free dry weight of skeletal muscle, were reported
by Young, Young and Edelman (1959). Burr and McLennan (1961) and
Fierles (1961) however, noted that potassium has an increased exchange
rate through the membranes of dystrophic skeletal muscle. Kandutsch
8

and Russell (1958} found a 203 decrease of muscle creatine on a wet
weight basis. Using infra-red analysis, Young, Young, and Edelman

(1959) observed that dystrophic skeletal muscle showed, (1) 923 increase in total lipids, (2) 1683 increase in triglycerides , (3) 1403
increase in total cholesterol, (4) 873 increase in non-esterified fatty
acids, but (5) a normal phospholipid content. Rabinowitz (1960) noted
that homogenized and fortified tissues of dystrophic mice have a greater
lipogenesis and cholesterolgenesis than their littermate controls. The
greatest differences observed by the above author were in brain tissue.
The difference in this tissue was closely followed by the differences
noted in liver and kidney tissues. Small differences were noted in spleen
and skin tissues, while those in muscle tissue were insignificant. He
stated, "that these results suggest that definite metabolic differences
occur in the various fat-metabolizing centers of the dystrophic mice."
Attention has been brought to bear on the enzyme activities within
the dystrophic muscle cell. Tassoni and Harmon (1961) reported that the
succinic dehydrogenase varied with the stage of the disease. In the
first two to four weeks following birth, the dystrophic and control
muscle were much the same in enzymatic activity. When five to seven
weeks old, the dystrophic animals showed lower activity while in the
seven to twenty week age group, the dystrophic animal showed considerably higher activity than the controls. Weinstock, Epstein and Milherat

(1958) stated that the activity of muscle succinoxidase was not affected.
Cytochrome oxidase and cathopsinactivity were markedly increased in
the muscles of dystrophic mice when compared to littermate controls.
They also showed that the aldolase activity of dystrophic muscle was
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decreased when based on wet or dry weight but was unchanged when based
on protein nitrogen or non-collagen protein

nitrogen~

Zierler (1958; 1961)

suggested that aldolase probably diffused faster from dystrophic muscle
than normal, which may be a reflection of increased permeability of the
muscle. Leonard (1957) found that in the skeletal muscles of the dystrophic mice, the "active" and "total" phosphorylase activities were significantly less than normal, but that the phosphorylase activity ration
were normal. He also stated that the glycogen concentration was higher
than normal in the dystrophic muscle. Rulon, Schottelius and Schottelius
(1962), in further studies on phosphorylase activity, reported that its
activity decreased with age in the dystrophic animal and that its activation
under lengthening stimulation was variable, while that of the control
animal showed progressive activation. They interpreted their results to
show that there is decreased glycogenolysis in dystrophic muscle with
advancing age of the animal. McCaman (1960) reported that some of the
enzymes requiring triphosphopyridine nucleotide as a cofactor (glucose6-phosphate dehydrogenase, isocitric dehydrogenase and glutamic
reductase) had an increased activity in dystrophic muscle, while some of
those requiring diphosphopyridine nucleotide as a cofactor (lactie dehydrogenase and alpha-glycerol-phosphate dehydrogenase) had a decreased
activity. Hazzard and Leonard (1959) found that phosphoglucomutase activity
was significantly lower in dystrophic leg muscle, determined as total
enzyme activity (at infinite coenzyme concentration)or as residual enzyme"'
coenzyme activity (in absence of coenzyme). The enzyme decreased with
the age of the mouse and with the severity of myopathy. They stated that
the "defect" seen appeared to be due to the loss of the coenzyme (glucose-I.
6 diphosphate). Rabinowitz (1959) studied the ratio of glutamic-oxalacetic
10

to glutamic-pyruvate transaminase and found that all tissues of the
dystrophic mouse exhibited higher activity with the sera showing the
greatest difference. McCaman (1960) has suggested that due to the
apparent increase in activity of the enzymes requiring TPN as a cofactor
and the apparent decrease in activity of those enzymes requiring DPN as
a cofactor, that abnormally high levels of reduced TPN or reduced
glutathione may bring about an altered intra-cellular metabolism. It
has been demonstrated (Rosenkrantz, 1959; Rosenkrantz and Laferte,
1960) that dystrophic mice exhibit an increase in triphenyltetrazolium
reducing activity (503 in liver, 433 in kidney and 253 in skeletal muscle).
By introducing specific substrates, it was found that muscle showed a
373 increase in glutamic acid dehydrogenase, but no significant change
in activity for succinic (see above), alphaketoglutaric, isocitric, betahydroxybutyric and malic dehydrogenases. Gould and Coleman (1961)
indicated that dystrophic muscle homogenates formed acetoacetate at a
much higher rate than normal muscle, but addition of sodium octanoate
did not result in formation of acetoacetate in dystrophic muscle as it did
in normal homogenates. They suggested that a heat labile factor in dystrophic muscle inhibited acetoacetate formation from octanoate. These
authors reported (1962) the existence of an extractable enzyme responsible
for acetoacetate formation in normal mice, but that it was not found in
dystrophic tissues. Baker, Bloom and Blahd (1959) studied the formation
of oxidation products of unsaturated fatty acids in homogenates of skeletal
muscle, heart, kidney, brain and liver by means of a thiobarbituric acid
assay. Their data suggested that the tissues of dystrophic mice did not
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show a regular and significant increase in the formation of oxidation
products of "fatty acid peroxides" over that of normal tissue.
Zymaris, Epstein, Sailer, Arousan and Volk (1959) reported that the
muscles of the dystrophic and control mice were qualitatively the same in
regards to adenosine monophosphate (AMP), adenosine diphosphate (ADP},
adenosine triphosphate (ATP}, diphosphopyridine nucleotide (DPN), quanosine triphosphate (GTP}, quanosine diphosphate (GDP), uridine diphosphate
(UDP}, enzyme creatine triphosphate (CTP) and inosine diphosphate (IDP).
However, they did find that quantitatively the AMP, GTP and GDP were
higher and that ATP was lower in the muscles of the dystrophic mice as
compared to the normal control animals. In a later study, Fymaris,
Sailer and Volk (1960) reported that by utilizing injected p32, they found
increased levels of ADP, DPN andGDP and no difference in AMP 2 ATP
and GTP in the dystrophic muscle. In another article (1962), these same
authors reported the above results as indicating an increased turnover
rate of ADP, DPN and GDP. Pennington (1961) studied mitochondrial
enzymes and found there was a 153 increase of ATP in the dystrophic
muscle but that the succinate -INT- reductase activity was normal in these
tissues.
Bond and Leonard (1959} found that both normal and dystrophic mice had
almost identical total blood, red blood cell and plasma volumes per 100
grams of body weight. Rabinowitz (1959) reported that the blood volume
per organ is smaller in the dystrophics. Oppenheimer, deLuca and
Milhorat (1959) studied paper electrophoretic patterns of sera from
dystrophic and normal littermate controls. They found no change in the
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relative concentrations of the protein fractions, but the patterns did
indicate a shift in distribution, particularly of lipoproteins and to a
smaller extent of g1ycoproteins. They also stated that the concentrations
in plasma of protein nitrogen, protein-bound lipids (free and esterified
fatty acids) and carbohydrates (hexoses, hexosamines and sia.lic acid) did
not vary significantly from controls. Baker, Tubis and Blahd (1958)
indirectly gave some attention to the endocrine glands. Finding that the
plasma levels of plasma glucose, cholesterol, protein-bound iodine131
and liver cholesterol were normal, they concluded that the pancreas and
thyroid must therefore be functioning properly. The data of K.andutsch
and Russell (1958) indicated that the dystrophic mice are able to remove
injected creatine from the blood stream more rapidly than the normals.
Several investigators have studied food consumption and urine excretion. Baker, Tubis and Blahd (1958) found that the dystrophic mouse
consumes more food per gram of body weight than normal, but may weigh
as much as 333 less than their littermate controls as reported by Bond
and Leonard (1958). Perkoff and Tyler (1958) demonstrated that the
Strain 129 mice excreted more creatine than creatinine, but there was
a reduction of urine creatinine in the dystrophic mice. They observed that,
"while there was creatinuria, it was less severe than human dystrophy."
They also noted that the dystrophic animal excreted the same creatine load
as did the controls. McGeer, McGeer, Miller, Derry and Nichol (1962)
reported essentially the same results. They interpreted these results to
point out a difference between the human and the mouse forms of muscular
dystrophy.
13

Kandutsch and Russell (1958) found that the urine creatine/creatinine
ratios were equal and that vitamin E injection did not reduce the creatin ..
uria of dystrophic animals to normal levels. McGaughey (1960) reported that
Strain 129 mice excreted more alphaketoglutarate and urea than other
species and strains of mice. He showed that the dystrophies excreted
significantly higher levels of alpha-ketoglutarate and urea/gm of body
weight than did controls, and that these differences increased from weaning to 4 months of age. However, no significant differences were observed
in urine excretion of amino acids, either in type or amount. It may be of
significance that Rabinowitz (1959) determined that glucose-cl4 was oxidized at the same rate in dystrophics and normal animals.
Various attempts have been made to halt or reverse the progress of
the disease and to prolong the life of dystrophic animals. Baker, Tubis
and Blahd (1958) tried administration of vitamins A, D, E, B-complex and
ascorbic acid and failed to alter the symptoms of dystrophy. These investigators (Tubis, Baker and Blahd, 1959) also reported that early therapy
with vitamins A, D, E, thiamine, riboflavin, pyridoxine, cyanocobalamine,
calcium pantothenate, niacinamide, folic acid, biotin, synthetic K, ascorbic
acid, unsaturated fatty acids and choline failed to prevent paralysis and
abnormal reflexes which are typical of the disease. The treatment had no
effect on the skin lesions, the convulsive seizures or the early death.
Hall, Hall and Nevis (1959) attempted parabiosis between dystrophic and
normal mice of the same sex and strain. Their results shpwed that survival
of dystrophics increased from a normal of 8 - 10 weeks to 24 weeks in males
and to 25 weeks in females. The characteristic signs in these animals were
often reduced in severity. Survival of the parabiotic pair was limited, due
14

to the development of cardiovascular disease, apparently as a consequence of parabiesis. However, Pope and Murphy (1960) could not
confirm these results. Their data indicated that a soft diet of high
quality will increase the life span of the dystrophic mice. Miller,
Wood and Gibson (1961) also recognized the importance of diet and
the effect of the disease on the animal's ability to feed.

They felt that

the.se points must be considered in any drug evaluation program. The
administration of 17-alpha-ethyl-19-nortestosterone did not restore
the lost function of the dystrophic muscle, but did seem to retard the
progress of the disease (Dowben, 1959). The administration of
Testosterone proprionate and estradiol benzoate was noted by Ershoff,
Alfin-Slater and Bernick (1961) to prevent osteoporosis of the hind
limbs but not to alter the course of the disease. Borgman (1963)
utilized methylandrostenediol dienanthoylacetate to prolong survival
time but it did not affect the disease process either.
The location of the initial lesion responsible for the disease state
has not been specifically defined by any one study or group of studies.
Indeed, it is painfully evident that as yet, no one biochemical locus
even appears more promising than others. Rosenkrantz and Laferte
(1960) are of the opinion, "that it is possible that the histopathological
similarities of nutritional muscular dystrophy, the inherited myopathy
of the mouse and human muscular dystrophy result from a biochemical
lesion at a different site in the same biochemical pathway or cycle."
Tubis, Baker and Blahd (1959) suggests, "that perhaps these animals may
have a hereditary induced vitamin deficiency, due to the fact that vitamins
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may not be incorporated into some necessary functional structure at
the cellular level. Kruh, Dreyfus, Schapira and Gey (1960) stated that,
"an acceleration of the turnover of the muscle proteins is probably the
most important abnormality of the muscle protein metabolism in dystrophic mice." Walker (1962) felt that the affected tfssues undergo accelerated "aging" and thus become "old" before the unaffected tissues.
Nichol, McGeer and Miller (1962) felt that the decreased creatine
kinase activity noted in dystrophic mouse skeletal muscle might be
responsible for early changes that are reflected in further disease.
Coleman (1961) linked dietary creatine and serum creatine levels to
kidney transamidinase levels and thus indirectly to creatine kinase
activity.
Several authors have questioned the relationship between the human
and mouse forms of dystrophy. Mc Geer, Mc Geer, Miller, Derry and
Nichol (1962) stated that the differences noted in creatine and creatinine
excretions may point to a basic difference in the diseases. In work on
creatine phosphorylkinase content, Read (1962) found that unlike human
muscular dystrophy, the dystrophic mouse muscle showed no difference
between its control. Golarz and Bourne (1960) stated that human
dystrophic muscle showed strong dephosphoralization in connective
tissue while dystrophic mouse muscle showed this activity only sporadically in capillary walls. These authors felt that this finding "may
mean the two diseases are not comparable."
The fact that it is not possible to question any of the above statements or
to regard one as more important than the others, is evidence of our present
ignorance of the exact nature of muscular dystrophy.
16

III.

STATEMENT OF THE PROBLEM

From the above data, several facts appear to point to the presence
of a biochemical lesion in the carbohydrate metabolism. Baker, Tubis
and Blahd (1958) reported that plasma glucose was at a normal level in
the dystrophic mice. Rabinowitz (1959) stated that glucose-cl4 was
oxidized at the same rate in dystrophic and normal mice. The rate, as
well as the route, of glucose metabolism is, of course, controlled by
enzyme activity. Glucose-6-phosphate dehydrogenase was at an increased
activity in dystrophic muscle (Mccaman, 1960), while phosphoglucomatase
was at a decreased activity, due to the loss of its coenzyme, glucose1, 6 diphosphate, according to Hazzard and Leonard (1959). Earlier,
Leonard (1957) reported that the "active" and "total" phosphorylase
activities were significantly less than normal, but that the phosphorylase activity ratios of dystrophic skeletal muscle were normal. The
activity of aldolase in dystrophic muscle was normal when based on noncoliagen protein nitrogen (Weinstock, Epstein and Milhorat, 1958). It
can be seen that glucose metabolism is "pointed" toward its being
utilized for energy, rather than storage. Mccaman (1960) reported that
alpha-glycerol-phosphate dehydrogenase was at a decreased activity, as
was lactic dehydrogenase. This latter enzyme is of importance in anaerobic glycolysis, and its decreased activity would seem to indicate that
dystrophic muscle relies mainly on aerobic glycolysis.
A number of enzymes important in aerobic glycolysis have been
studied. Rosenkrantz and Laferte (1960) found no significant increase
in the activity of isocitric dehydrogenase by their technique. However,
17

using another method, Mccaman (1960) did report an increase in the activity of this enzyme. Rosenkrantz and Laferte (1960) reported that alphaketoglutaric acid dehydrogenase activity was not significantly varied in
dystrophic muscle, nor was the activity of succinic dehydrogenase altered.
Tue activity of muscle succinoxidase was not affected, according to
Weinstock, Epstein and Milhorat (1958). Malic dehydrogenase did not
vary in muscles of dystrophic mice from that activity of normal muscle
(Rosenkrantz and Laferte, 1960). Zymaris, Epstein, Saifer, Arousan and
Volk (1959) reported on the muscle content (dystrophic and normal mice)
of many of the coenzymes and cofactors necessary for metabolism. They
found that dystrophic muscle had quantitatively higher amounts of adenosine monophosphate, guanosine diphosphate and guanosone triphosphate
than did normal muscle. However, the dystrophic muscles were quanti ....
tatively lower in their content of adenosine triphosphate, the substance
thought to provide immediate energy for work by all cells of the body.
These above mentioned enzymes and cofactors all point to the fact that
the tricarboxylic acid cycle is functioning properly, if not at an increased
rate. Further evidence of this fact seems to be evident. Cytochrome oxidase
is at an increased activity, according to Weinstock, Epstein and Milhorst
(1958). This indicates that metabolism is accelerated, as does the reported finding of Rosenkrantz and Laferte (1960) that muscle oxygen uptake
is increased. The report that cathepsin activity in muscle is greatly increased (cathepsins are those enzymes responsible for protein breakdown)
by Weinstock, Epstein and Milhorat (1958) and that there is an increased
muscle protein turnover (Simon, Lessell, Gross and Milhorat, 1958; Coleman
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and Ashworth, 1959; Kruh, Dreyfus, Schapira and Gey, 1960) all indicate
that carbohydrate metabolism must be increased in order to provide the
energy necessary for the increased rate of muscle protein synthesis.
It becomes obvious that if there is an increased carbohydrate
metabolism, there must be an increased source of the raw material.
Baker, Tubis and Blahd (1958) found that the dystrophic mouse consumes
more food per gram of body weight than does its littermate control. However, Bond and Leonard (1958) found that the dystrophic mouse may weigh
as much as 333 less than its littermate control. Thus, it is seen, that
dietary intake cannot supply the now increased demand for carbohydrate.
When proteins break down, they are reverted back to their original form
as amino acids. These amino acids, in the course of their metabolism,
are first deaminated. Rabinowitz (1959) found that all tissues of the
dystrophic mouse have increased transaminase activity. The function of
a transaminase is to take the amino group from one compound and place it
on another. If these enzymes are at an increased activity, then the
deaminated amino acids would be at a greater concentration. These deaminated amino acids may be easily incorporated into the tricarboxylic
acid cycle. Thus, with an increased diet and the availability of deaminated amino acids, the tricarboxylic acid cycle would have more substrate available for the production of more energy. Also, because of
the increased rate of deamination of amino acids, more urea would be
formed from the increased amount of amino groups liberated by the deamination. An increased urea excretion by littermate control and dystrophic
mice of Strain 129 had been reported by McGaughey (1960). This would
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seem to indicate that there is an increase in amino acid deamination.
However, McGaughey (1960) also reported an increase of alphaketoglutaric acid in the urine of these same animals. His findings
indicated that the dystrophic mouse excreted a significantly higher
amount than did the littermate controls, and that this difference increased from weaning to 4 months of age (normal time of death). If the
tricarboxylic acid cycle is operating properly, this substrate should
not be found in the urine. It could come from several sources. If
alpha-ketoglutarate dehydrogenase were at a decreased activity, the
increased glucose metabolism would "flood" the enzyme and the excess
would spill out into the urine. However, Rosenkrantz and Laferte (1960)
reported it to be at normal activity. The kidneys could play a part
also in the excretion of alpha-ketoglutaric acid. It is known that
deamination of glutamic acid yields alpha-ketoglutaric acid. Glutamic
reductase is at an increased activity (McCaman, 1960) as is glutamic
acid dehydrogenase (Rosenkrantz and Laferte, 1960). These enzymes then
could be responsible for the alpha-ketoglutaric acid excess found in the
urine of Strain 129 mice (McGaughey, 1960).
It became the object of this study to determine if alphaketoglutarate
dehydrogenase is responsible for this excretion of its substrate.
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IV.

EXPERIMENTAL METHODS

The mice studied were dystrophic (dydy) and heterozygous "carriers"

(Dydy from Strain 129/Re+dy. The notation 129/Re+dy designates the
subline of the 129 inbred strain in which the dystrophic (dydy) mutation rose. The mice were obtained from the Russell B. Jackson Memorial
Laboratories, Bar Harbor, Maine, and were approximately 2 months when
received. They were kept in 12" x 12" wire screen cages in well ventilated, air conditioned animal quarters. They were fed Purina laboratory
chow and allowed water ad libitum.
The animals were given an intra-peritoneal injection of sodium
pentobarbital (40 mg/kg). The gastrocnemius muscles were quickly excised and placed in a covered weighing bottle set in cracked ice.
Motor end plates were stained using the vital methylene blue technique of C~~rs and Woolf (1959). The injection of the dye into the unfixed muscle and the subsequent exygenation formed a stable dye-lipid
complex which selectively deposited the blue dye on the bare nerve endings. Although the exact mechanism of this selectivity is unknown, the
procedure constitutes an excellent means of studying gross morphology of
nerve terminal arborization.
The co'~rs and Woolf (1959) histochemical technique for staining
cholinesterase was utilized for the study of post-synaptic membranes.
This technique was originally outlined by Koelle and Friedenwald (1949)
and modified by Couteaux (1951). In this method, cholinesterase, con centrated in the lamellae of the post-synaptic membrane, is complexed by
a disulfide bond. This complex appears as fine black granules on the
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prepared slide, and thus presents a picture of the post-synaptic membrane.
Cholinesterase activity was determined by the method of Augustinsson
(1948). This method measures the carbon dioxide evolved from liberated
acetic acid when acetylcholine as a substrate is hydrolyzed by cholinesterase.
The determination of the non-collagen protein nitrogen was made
using the technique of Lilenthal, Zierler, Folk, Buka and Riley (1950).
The method of Lanni, Dillon and Beard (1950) was used for wet combustion
followed by direct nesslerization using the Nessler's reagent of Koch
and McMeekin (1924). These methods provided a suitable and accurate
reference basis for the comparison of muscles in which one group (dystrophic) differed significantly from the other (littermate control) in fat,
collagon and protein content.
Alpha-ketogluterate dehydrogenase activity was determined by the
procedure of Kaufman, Gilvary, Cori and Ochoa (1953). The Warburg apparatus was set to oscillate at 90 cycles per minute, with a shaking amplitude of approximately 7 cm. The water bath was maintained at 25° C.
This method determined the activity of the enzyme by measuring the release of carbon dioxide from alpha-ketoglutaric acid, according to the
metabolic scheme as summarized by Cantarow and Schepartz (1957). The
results are expressed as microliters of carbon dioxide released per mg
of fat-free, non-colliagon protein nitrogen in the tissue sample.
Creatine phosphokinase was isolated by the first two steps of procedure B of Kuby, Noda and Lardy (1954). The enzyme activity was measured
using the technique of Read and Nehorayan (1959). Phosphate was deter-
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mined by the method of Fiske and Subbarow (1925). This method followed
the enzyme activity by measuring the amount of phosphorus enzymatically
transferred from ATP to creatine.
Alpha-ketoglutaric acid was measured in the muscle by the following
procedure, modified from McGaughey (1960). The gastrocnemius muscles
were removed and homogenized in 5 times their weight in distilled water.
T\vo ml of 0.1% 2. 4-dinitrophenylhydrazine (DNPH) in 2N HCl were added to
the homogenate and allowed to stand for 15 minutes. The homogenate-DNPH
mixture was then extracted with 2 ml of ethyl acetate. T\vo ml of IN
Na2co 3 was added to the ethyl acetate extract, the solution acidified
with 2N HCI and the Na2C0 3 extracted with 5 ml of ethyl acetate. The
optical density of the ethyl acetate was measured at 480 mu in a spectrophotometer (Bausch and Lomb, Spectronic 505). A reagent blank was run
on I ml of redistilled water simultaneously with the sample. Standards
of I, 3 and 5 mg of alpha-ketoglutaric acid in 1 ml of redistilled water
were extracted in the same manner and similarly analyzed. The method
eliminates most of the contaminants and excess DNPH and converts alphaketoglutaric acid to the yellow hydrazone salt.
The metabolism of pyruvate was studied in order to determine the
efficacy of the tricarboxylic acid cycle. Radioactive labeled pyruvate
was utilized. Injections of 0. 5 ml of saline containing 10 microcuries
of activity of pyruvate-2-cl4 were made into the intraperitoneal cavity
of dystrophic and littermate control mice. The mice were isolated and
separated in all-glass metabolism cages (Roth, Leifer, Hogness and Langham, 1948) in which urine, food and feces were individually separated.
The exhaled carbon dioxide was collected in KOH and BaC1 2 • One half of
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the 24 hour urine volume was extracted for alpha"ketoglutaric acid as
stated above, with the exception that the last ethyl acetate fraction
was 2 ml. The other half of the 24 hour urine volume was dried on a
planchet. The extracted urine, in the form of the ethyl acetate frac"
tion, was also dried on another planchet. The collected cl402 now in
the form of Bacl 4 03 was plated on another planchet (150 mg Bacl403).
The planchets were counted in a Geiger tube, model D47.
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V.

EXPERIMENTAL RESULTS

Motor End Plates
The terminal end plates and subterrninal fibers of dystrophic and nondystrophic littennate control mice are compared in figures 1 and 2. The
terminal end plates are stained with methylene blue. This method employs
methylene blue as a non-specific stain for the lipoida.l substance of nerve
terminals and gives infonnation on only the gross morphology of the end
plates and branching of the subtenninal fibers.
In figure l is shown a single motor end plate of non -dystrophic control

stained with methylene blue. In longitudinal sections of whole muscles
(as in figure 1) the motor end plates are concentrated in narrow zones
(innervation terminal band) situated at the mid-point of the muscle

"
(Coers,
1953). Figure 1 represents such a motor end plate. It has been
selected because it represents a typical end plate found in mice skeletal
muscle. It can be seen that the subterminal nerve fibers (black wavy lines

Figure 1. Motor-End Plate From A Littermate Control Gastrocnemius
Muscle. Methylene Blue Technique. 1150X
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in upper right of figure 1) become increasingly separated from one

another as they proceed distally. Titey weave in front of or behind the
muscle fibers, crossing them approximately perpendicular. TI1e rerminal fibers rllll only a short course, ending in a terminal arborization
on the surface of a muscle fiber. TI1e terminal arborization, in methy-

lene blue preparations, show some branching with swellings on the branches.
The branches end, not in a tapered point, but in a terminal enlargement.
Functionally, these endings make contact with the post-synaptic membrane,
a specialized portion of the muscle membrane.
In figure 2 is shown a single motor end plate on a muscle fiber ta.ken

from a dystrophic mouse. While it is somewhat smaller and exhibits
less branching than does the motor end plate f:rom the normal mouse, it
is still within normal limits. The terminal arborization shows

Figure 2.

branching~

Motor ..End Plate From A Dystrophic Gastrocnemius Muscle.
Methylene Blue Technique. l 150X

with swellings on these branches. Adams, Denny-Brown and Pearson
( 1953) described motor end plates in human dystrophic muscle. They

found that these structures were smaller and some showed "clubbing"

26

of the entire unit. Figure 2 ha.s no such "clubbing" but it is smaller
and appears less developed than the normal unit. These differences that
are noted are not of a significant nature . They represent functional
changes due to the disease present in the muscle cell. Adams, DennyBrown and Pearson (1953) ascribed the differences noted in human muscles
to the fact that the muscle fiber which the unit innervates has undergone
degeneration, and perhaps complete dissolution. The nerves to these
fibers undergo atrophy more slowly, and thus they are seen to be smaller
and less developed.
Post-Synaptic Membranes
The post-synaptic membrane taken from the skeletal muscle of a
littcrmate control mouse is shown in figure 3. It is typical of the appearance of these structures as found in these mice and stained with
this procedure(Augustinsson, 1946). The black precipitate is located
within the lamellae of the membrane and thus presents a picture of the

Figure 3. Post-Synaptic Membrane From A Littermate Control Gastrocnemius
Muscle. Cholinesterase Stain. Koelle & Friedenwald (1949)
Technique. llSOX
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structure. This specialized area in the muscle membrane is functionally
able to receive nerve impulses from the nerve terminals which make
ftUlctional contact with this membrane. The post-synaptic membrane
follows the pattern of the motor end plate, as shown in figure 3 .
Tue post..synaptic membrane of the dystrophic mouse skeletal muscle
is seen in figure 4 . TI1e thickness of the sections necessary for this staining procedure make it difficult to obtain photographs. The membrane may

be situated at a slight angle to the objective of the microscope. Thus,
the examiner must focus in several points along the membrane in order
to study the structure in its entirety. However, the camera cannot

Figure 4 .

Post-Synaptic Membrane From A Dystrophic Gastrocnemius Muscle .
Cholinesterase Stains. Koelle & Friedenwal<l (1949) Technique.

ll50X
change focus in this mam1er and the resulting photograph is a composite view
of the object being viewed. TI1is is seen in figure 4. T11is figure was included
because it showed typical morphology when seen under the microscope. Microscopically, the post- synaptic membranes conformed closely to the morphology
of their respective motor end plates and there appeared to be no significant
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gross difference between dystrophic muscle and littermate controls.
Quanta tive Cholinesterase Determination
The histochemical demonstration of cholinesterase by the Koelle and
Friedenwald technique cannot be considered as quantative. In a series of
slides prepared for demonstration of the post-synaptic membranes by this
method, the dystrophic animals gave a faint staining reaction when compared to the bold staining reaction of the littermate controls. It was therefore decided to determine the cholinesterase activity in a quantative manner.
Cholinesterase was determined by the method of Augustinsson (1948). The
results are shown in table 1. The test is a measurement of the carbon
dioxide evolved from liberated acetic acid when acetylcholine as a substrate.
Table I.
Quantative Cholinesterase Determination of Skeletal
Muscle of Dystrophic and Littermate Control Mice
LITTERMATE CONTROL

DYSTROPHIC

Microliters of C02 released/mg fat-free, non-collagen nitrogen/ 40 minutes
Animal (I)
(2)
(3)
(4)
Average

*

32.5
34.1
35.5

Animal

(!)

(2)
(3)
(4)

33.7

33.95\-0.62*

31.6
33.4
32.8
34.4
33.05+0.59

\ rTr;2

V~i::Ir

is hydrolyzed by cholinesterase. The volume of carbon dioxide (in microliters) is then referred to milligrams of non-collagen nitrogen as a reference
base. The experiment was run for 40 minutes. The results show that there
is no significant difference between control and dystrophic animals.
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Thus,

the difference noted in the staining intensity between the two groups may
have been due to the fact that the smaller dystrophic muscle simply did
not contain as much cholinesterase per unit area and therefore gave a
less intense staining reaction.
Fat-Free, Non-Collagon Protein Nitrogen
It is known that there is an increase in fat in the dystrophic muscles
(West and Murphy, 1960). Therefore, the wet weight as a reference base
would not be satisfactory for quantative work because the two muscle
groups differ in their fat content and any comparison on this basis would
not reflect a true quantative comparative value. The collagen content is
also increased in dystrophic muscle (West and Murphy, 1960) and therefore
the fat-free, dry weight base is also inadequate for the same reason as
given above. Lilenthal, Zierler, Folk, Buka and Riley (1950) have shown
the validity of the fat-free, non-collagen protein nitrogen as a quantative
reference base. Therefore, the fat-free, non-collagen protein nitrogen
was selected as a reference base for the comparison between the two muscle
groups. Table 2 shows the variation in the fat-free, non-collagen protein
nitrogen content of skeletal muscle of hystrophic and littermate control mice.
The dry weight of both groups were the same, averaging 23-243 of the wet weight.
However, the fat content of the dystrophic muscles was

93 as

compared to

43 in the littermate control muscles. These results then, seem to agree with
the work of West and Murphy (1960), who reported histological evidence of
fatty replacement

m dystrophic

muscle. Weinstock, Epstein and Milhorat

(1958) found 18.9 mg of non-collagen nitrogen in littermate control muscle
and 16. 3 mg in dystrophic muscle.
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The results expressed in table 2 are in

good agreement with their results. The reduction of protein nitrogen in
Table 2.
The Fat-Gree, Non-Collagen Protein Nitrogen Content of Dystrophic and
Littermate Control Mice Skeletal Muscle

Dry Wgt.
of Wet.

3
Littermate Control (1)

(2)
(3)
(4)
(5)
(6)

23
24
23
22
26
23
23.°8-t-O. 48 *

Average
Dy strophic

Fat-Free Dry Wgt.
3 of Wgt.

(1)
(2)
(3)
(4)
(5)
(6)

Average

23
23
23
22
23
23
22.8+0.17

Non-collagen
nitrogen mg/gm

19
21
19
22
19
19
-W.8+0.54
14
15
17
14
10

14
14.0+0.85

18. 9
20.2
19.4
16.6
18.3
16.4
18.3+0.62
17.8
14.4
13. 7
16.3
15.4
14.8
15.4+o.16

·wct2

n(n-1)

dystrophic muscle is approximately 153, which is significant. Therefore,
because the non-collagon nitrogen is reduced in dystrophic muscle, it is
necessary to recognize this fact when comparing dystrophic to littermate
control muscle. Thus, the fat-free, non-collagen protein nitrogen reference
base provides a suitable and reasonably accurate reference base for com paring dystrophic and littermate control muscle.
Creatine Phosphokinase
The results are presented in table 3. It can be seen that dystrophic
and littermate control muscles do not vary significantly in their levels
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of activity. Thus, the dystrophic muscle is able to store high-energy
phosphate bonds as readily as the littermate control muscle.
Table 3.
Crea tine Phosphokinase Activity of Skeletal Muscle of
Dystrophic and Littermate Control Mice

Littermate Control

Dy strophic

J'.N P transferred from ATP to creatine/ gm fat-free,
non-collagen prptein nitrogen/2-1/2 minutes
Animal (1)
(2)
(3)
(4)

12.3
10.0
10.4
9.2

Animal (1)
(2)
(3)
(4)

11. 5
9.0
9.2
10.8

Average

10.5\.-1.1*

Average

10. l+o.8

Alpha-Ketoglutarate Content of Muscle
McGaughey (1960) reported that both dystrophic and lettermate control
of Strain 129 mice excreted more alpha-ketoglutarate and urea in their
urine than did other strains of mice. Before approaching an enzymatic
study, it seemed desirable to check the content of skeletal muscle as a
means of determining if simple accumulation of alpha-ketoglutarate in
muscle could account for the increased urinary excretion.
The alpha-ketogluterate content of the skeletal muscle of dystrophic
and littermate control animals is shown in table 4. The results are expressed as mg of alpha-ketoglutarate per gram of fat-free, non-collagen
nitrogen.
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Table 4.
Alpha-Ketoglutarate Content of Skeletal Muscle from Dystrophic,
Littermate Control Mice and Normal White Mice

Litterma te Control

Dy strophic

Normal White

Mg alpha-ketoglutarate/gm fat-free, non-collagen nitrogen
(1)
(2)

150
llO

(1)
(2)

0
0

(1)

160

The alpha-ketoglutarate in the littermate control averaged 130 mg/gm
fat-free, non-collagen nitrogen while a normal white mouse gave a
figure of 160, which is well within the range of the littermate control.
The dystrophic muscle had no alpha-ketoglutarate, at least it was· below
the minimum detectable by the test procedure. As the purpose of the
test was to determine if a significant increase in muscle alpha-ketogluarate
could account for the increased urinary excretion, it was felt that a
limited number of animals would answer this question. The inability to
detect alpha-ketoglutarate in dystrophic muscle would indicate against
the concept that the alpha-ketoglutarate found in the urine is a result of
this compound accumulating within the substance of dystrophic muscles.
Alpha-Ketoglutarate Dehydrogenase

In a further search for the biochemical lesion responsible for the
increased urinary excretion of alpha-ketoglutarate, the alpha-ketoglutarate
dehydrogenase activity was measured. This enzyme is responsible for
the first step in the metabolism of alpha-ketoglutarate. A reduction
in the enzyme level would result in a lowered ability to metabolize
alpha-ketoglutarate and result in its excretion.
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The alpha-ketoglutarate dehydrogenase activity of skeletal muscle
from dystrophic, littermate controls and normal white mice is shown
in table 5. The normal white mice are included to record a strain
difference in the mice. The results show that the littermate control
Table 5.
Alpha-Ketoglutarate Dehydrogenase Activity of Skeletal Muscle from
Dystrophic, Littermate Controls and Normal White Mice

Littermate Control

pl C02 released per

Dy strophic

gm fat-free, non-collagen nitrogen per 4 minutes.

Animal (I) 5.87
(2) 4.82
(3) 5.87
(4) 7.63
Average

Normal White

6.0St0.62*

Animal (I) 10.61**
(2) 11.~
(3) 9.09
(4) 9 .09
Average

Animal (I}
(2)
(3)
(4)

10.04+0.57 Average

*"V.:. ~d2
Il(n-1)
** Each run represents tissue pooled from

8.43
8.22
8.82
8.22
8.42-+0.14

2 animals

mice have a dehydrogenase activity of 6. 05 microliters per mg fat-free,
non-collagen protein, while the dystrophic muscle gave a figure 653
above this. The difference of the two means is statistically significant
(P •. 01). These results are consistent with the low alphaketoglutarate
content of dystrophic muscle, whereby the high level of enzymatic
activity is sufficient to keep the alpha -ketoglutarate content low. It is
also consistent with the adequate and normal level, when compared to
normal white mice, of alpha-ketoglutarate content of the littermate
control skeletal muscle. The depressed alpha-ketoglutarate dehydrogenase activity of littermate controls, 6.05 as compared to 8.42 for
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normal white mice, at least is consistent with the alpha-ketoglutarate
content of these muscles.
Pyruvate-2-cl 4 Metabolism
The results of this study are shown in table 6. To check the posibility
of the tricarboxylic acid cycle as a possible source of the excess alphaketoglutarate found in the urine, the metabolism of radio-active pyruvate
was studied. It was felt that there was sufficient evidence that the
tricarboxylic acid cycle was functioning and therefore, even a very
limited study would be sufficient to clarify this point. Both the dystrophic
and littermate control mice were able to metabolize pyruvate. Radioactive labeled carbon dioxide was detected in the exhaled air of these
animals.

The urine revealed the presence of cl4, of which a part was

in the form of alpha-ketoglutaric acid. These results may be interpreted
Table 6.
Pyruvate-2 .... cl4 Metabolism of Dystrophic and Littermate Control Mice

Urine
Counts per Minute
Untreated*

Exhaled C02***

Extracted**

Littermate Control*

18' 191

4,060

1,522

Dy strophic

12,418

2,630

1,067

*
*

**

Both groups received 10 microcuries of cl4 labeled pyruvate
One-half of the 24 hour urine volume
The ethyl acetate fraction of the extracted 24 hour urine volume
Counted as 150 mg of Bacl403

***
as showing that a

part of the alpha-ketoglutaric acid found in the urine of

Strain 129 mice is originating from pyruvate metabolism. As pyruvate
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is a product of glucose metabolism, it may be further postulated that glucose
metabolism contributes to the alpha-ketoglutaric acid found in the urine of
these animals. It is also possible that rapid conversion of alanine to pyruvate is the pathway to the excess alpha-ketoglutarate.
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VI.

DISCUSSION

Michelson, Russell and Harman (1955) reported that there was an
absence of apparent lesions in the nervous system of the dystrophic
mice. They did not, however, include studies on the motor end plated
and post-synaptic membranes. The present report is consistent with
the view that the muscular dystrophy of mice is a disease of muscle and
does not involve the nerve terminals.
A consistent observation in all studies of muscular dystrophy is the
increased excretion of urinary creatine, decreased excretion of
creatinine and a decreased ability to retain injected creatine (Milhorat
and Wolff, 1937). The work of Benedict, Kalinsky, Scarrone, Wertheim
and Stetten (1955) incicated, at least in human patients, that no defect
existed in creatine synthesis but that the excess urinary creatine was
due to an inability of creatine to enter the muscle cell. Heinrich and
Mattill (1949) concluded that the increased urinary excretion of creatine
of vitamin E-deficient rabbits was due to defective phosphorylation of
creatine. Hummel (1948) agreed with the latter viewpoint, for, in his
experiments with tissue homogenates, skeletal muscle from vitamin
E-deficient rabbits had a low ability to phosphorylate creatine. It had
been reported that muscle creatine is the precursor of urinary creatinine
(Block, Shoenheimer and Rittenberg, 1941), a reaction which proceeds
through a preliminary phosphorylation of creatine within the muscle cell
(Ennor, Rosenberg and Armstrong, 1955). The low activity of the enzyme,
creatine phosphorylkinase, was interpreted to mean that the non-phosphorylated creatine was unable to be transferred into the muscle cell and hence
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was excreted. However, Dinning and Fitch (1958) showed that the turnover rate of creatine was elevated in skeletal muscle of vitamin E-deficient
rabbits. This implied that, rather than not being able to penetrate the
muscle cell, the creatine molecule was able to penetrate at even a greater
than normal rate. Read and Nehorayan (1959) showed that in early vitamin
E-deficient rabbits, at a time when the urinary creatine excretion was
rising, the enzyme, creatine phosphorylkinase, was higher than normal.

The

latter authors then rejected defective phosphorylation as causing the urinary
excretion, in conformity to the results of Dinning and Fitch (1958).
The above discussion concerning vitamin E-deficient animals is not
intended to imply a similarity between the vitamin deficiency and muscular
dystrophy. It is intended to call attention to hypotheses concerning the
origin of the increased urinary creatine.
To carry the analysis further, Feuer and Wollemann (1952) reported
that creatine was bound to the actin molecule. They further suggested
that creatine phosphorylkinase, bound to actin, was necessary for actin
p0Jyme:tizatio11. Strohman (1959) recently reported that the creatine
phosphorylkinase system is intimately concerned in actin polymerization
by reversible phosphorylation-dephosphorylation of the actin bound
nucleotide. Read (1960) submitted tentative evidence for the participation
of creatine in actin polymerization which suggested that creatine was
bound to actin and participated in actin polymerization by serving as the
phosphate acceptor from actin bound nucleotide during polymerization.
This reaction is enzymatically catalyzed by creatine phosphorylkinase.
Hence, by inference, deficiency of creatine phosphorylkinase, leads to
a deficiency of actin polymerization and an inability to contract. Indeed,
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Read and Johnson (1959) reported data on foetal rabbits, which showed
that, in skeletal muscle, the appearance of the enzyme, creatine
phosphorylkinase, occurs coincident in time of foetal development with
the appearance of contractility. Hence, in any study of the specific
biochemical lesion of muscular dystrophy, the demonstration of depressed activity of creatine phosphorylkinase is of importance and
could explain most of the symptoms. Pertinent to the present discussion,
is the report of Ronzoni, Wald, Berg and Ramsey (1958) who stated that
the creatine kinase activity of skeletal muscle of human muscular dystrophy is only 20 to 40 percent of normal control muscle. This would
indeed suggest at least the possibility of deficient phosphorylation as
the cause of the inability of muscle to incorporate and retain creatine
and explain many of the dystrophic symptoms. While some criticism
of this work can be made on the grounds of a rather crude enxyme
preparation, the necessity of excessively small samples from humans
precludes extensive purification. Their data is suggestive and should
be explored further.

The data reported in the present work indicates

that the enzyme levels of dystrophic and normal mouse muscle do not
differ.

This discrepancy between human and mouse dystrophic muscle

is important, to resolve, for it may indicate a fundamental difference
between human and mouse dystrophy.
It is readily apparent that the activity of alpha-ketoglutarate dehydrogenase is greatly increased in the skeletal muscle of dystrophic mice.
This increase in activity may be due to an increase in the amount of
alpha-ketoglutaric acid "delivered" to the enzyme for metabolism.
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Protein anabolism and catabolism are increased in the dystrophic mice
(Simon, Lessell, Gross and Milhorat, 1958; Coleman and Ashworth,
1959; Kruh, Dreyfus, Schapira and Gey, 1960). The amino acids thus
liberated from protein breakdown will be available for re-synthesis, or
may be metabolized. Deamination is the first step in the metabolism of
amino acids. It has been reported (Rubinowitz, 1959) that the ratio of
glutamic-oxalacetic transaminase to glutamic-pyruvate transaminase is
increased in all tissues of the dystrophic mice, with the sera showing
the greatest difference. Chowdhury, Pearson, Fowler and Griffith (1960)
have reported increased serum transaminase levels in human patients
with progressive muscular dystrophy. Thus, if the transaminases are
increased in this disease, it can be seen that the deamination of the now
increased production of amino acids from the increased protein breakdown will result in more substrate for the tricarboxcylic acid cycle and
an increase in amino groups. These amino groups may then be transferred to alpha-ketoglutaric acid forming glutamic acid. As glutamic acid
acid dehydrogenase activity is increased in dystrophic muscle (Rosenkrantz,
1959) this new load of amino groups can be passed to the ornithine-citrullineurea cycle without "backing up" at the glutamic acid site. If this portion
of protein metabolism is functioning at an increased activity, it can be
seen that the high amounts of urea found in the uririe of the dystrophic
mice (Mc Ga ughey, 1960) is an expected finding.
When glutamic acid passes its amino group to the urea cycle, alphaketoglutaric acid is regenerated and made available for further transamination
of amino acids, and the eventual production of urea. An increase in oxygen
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consumption in dystrophic muscle has been reported by Rosenkrantz
and Laferte (1960); cytochrome oxidase is reportedly increased, also
(Weinstock, Epstein and Milhorat, 1958). These increases may be
interpreted as indicating an overall increase in the activity of the tricarboxcylic acid cycle.

Thus, additional alpha-ketoglutaric acid may be

formed to help in the deamination of amino acids. However, McGaughey
(1960) reported an increase in alpha-ketoglutaric acid in the urine of
Strain 129 mice, with the dystrophic mice having a significantly higher excretion than the normals. This study has ffiown that alpha-ketoglutarate
dehydrogenase is at an increased activity in the dystrophic leg muscles. This
finding, then, does not explain the data of McGaughey (1960). The preliminary study in this paper seems to indicate that pyruvate metabolism through
the tricarboxcylic acid cycle to alpha-ketoglutaric acid is functioning, and
that a portion of the alpha-ketoglutaric acid found in the urine of the dystrophic mice may come by way of this route. In view of these findings, it
appears as if an excess of alpha-ketoglutaric acid is formed through the
increased protein breakdown, resulting in increased amino acids (in
particular, glutamic acid which may be deaminated by glutamic acid
dehydrogenase and thereby directly form alpha-ketoglutaric acid) and an
increased activity of the tricarboxcylic acid cycle.

This excess production,

resulting in the presence of alpha-ketoglutaric acid in the urine of Strain
129 mice, may then exceed the metabolism of alpha-ketoglutaric acid
by the tricarboxcylic acid cycle, or it may be a function of the kidneys, or
a combination of these two factors.
The littermate control mice present s:>mewhat of a different problem.
This strain of mice presents two distinct genetic groups, represented as
129/Re-ldy subline and 129/J subline (communication from Russell B. Jackson
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Memorial Laboratory, Bar Harbor, Maine). The 129/J subline is referred
to as DyDy (homozygous normal controls) in which dystrophy has not been
reported.

The subline 129 /Re dy has the given genetic description of

Dydy (heterozygote, or littermate control), Dy? (control) and dydy
(dystrophic). The animals used as controls in this stutly were of the Dydy
and Dy? groups. It is apparent that these animals may have a predisposition toward dystrophy and that their label of "normal" is based on the
absence of clinical signs of the disease.

Thus, though they differ from

normal white mice and the dystrophic mice activity levels, an attempt to say
that the difference is of etiological importance is rather presumptuous.
However, this fact cannot be completely disregarded. The explanation, of the
lowered activity in these animals, must await more refined techniques in
the correlation of disease with heredity.
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VII.
1.

SUMMARY

Gastrocnemius muscles of dystrophic mice present essentially

the same pattern as normals in regard to motor end plates and postsynaptic membranes.
2.

Alpha-ketoglutarate dehydrogenase activity is increased in

dystrophic leg muscle as compared to littermate controls. Normal
white mice leg muscles have an activity that is intermediate between
littermate control and dystrophic leg muscles. This increase in dystrophic muscle may be expected, due to an increase in activity of the
tricarboxcylic acid cycle and an increase in protein breakdown.
3.

Crea tine phosphokinase activity does not vary significantly

between dystrophic leg muscle and littermate control leg muscle.
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